Cell Therapies 101: What Are Stem Cells and Why Do They Matter?
Researchers are harnessing the power of stem cells to generate functional beta cells and islets, driving us closer toward type…
Cell therapy first: transplanted islets working without immunosuppressives
Today, Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets…
2024 Greatest T1D Hits: A Glance at This Year’s Achievements
With the holiday season in full swing, we have many reasons to be thankful. While we look back on 2024,…
Clinical Trials in Action: Aiedan’s Story
Meet Aiedan, a participant in the T1D RELAY clinical trial that aims to preserve insulin production in those newly diagnosed…
Reflecting on 50 Years with Type 1 Diabetes
Phyllis Kaplan, who has lived with type 1 diabetes for 50 years, reflects on progress made thanks to Breakthrough T1D.
Putting the Foxes in Charge of the Henhouse: The Dramatic Race to Develop an Artificial Pancreas
The true story of how artificial pancreas systems moved from an idea to a therapy, improving the lives of millions…
Meet Alecia Wesner, a hero for T1D clinical trials
Since 2014, Alecia Wesner has participated in numerous T1D clinical trials, many of which were early artificial pancreas system trials.
Meet Liz Walsh, a hero for pregnancy with T1D
Thanks to advancements in type 1 diabetes treatment and care, Liz Walsh had a complication-free pregnancy with T1D.
Vertex launches pivotal trial for stem-cell derived islet therapy
On Monday, Vertex made a monumental announcement. Their Phase 1/2 trial for VX-880 is converting to a Phase 1/2/3 pivotal…
FDA Advisory Committee does not recommend that sotagliflozin receive approval for glucose lowering in adults with type 1 diabetes (T1D) and Chronic Kidney Disease (CKD)
Update – November 22, 2024 This morning, Lexicon Pharmaceuticals, Inc. (Lexicon) announced they received a “deficiencies preclude discussion” letter from…
